According to SEC filings for the period ending December 2025, Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is held by 18 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 30 Sep, 2025 | 2,860,000 | 0 | 0.00% | $62,147,800.00 |
| EcoR1 Capital, LLC | 30 Sep, 2025 | 2,030,544 | 0 | 0.00% | $44,123,721.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 1,704,361 | 172,650 | 11.27% | $37,035,765.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 1,344,115 | 31,942 | 2.43% | $29,207,619.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 1,175,951 | 0 | 0.00% | $25,553,415.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 586,046 | 76,478 | 15.01% | $12,734,780.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 574,030 | -18,835 | -3.18% | $12,476,472.00 |
| ROYAL BANK OF CANADA | 30 Sep, 2025 | 479,193 | 474,128 | 9,360.87% | $10,413,000.00 |
| Westside Investment Management, Inc. | 30 Sep, 2025 | 472,540 | -250 | -0.05% | $10,267,577.00 |
| CANNELL CAPITAL LLC | 30 Sep, 2025 | 455,405 | 67,230 | 17.32% | $9,895,951.00 |
| STATE STREET CORP | 30 Sep, 2025 | 438,445 | 115,251 | 35.66% | $9,527,410.00 |
| THOMPSON SIEGEL & WALMSLEY LLC | 30 Sep, 2025 | 418,566 | 37,301 | 9.78% | $9,095.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 351,417 | 108,837 | 44.87% | $7,636,291.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 324,621 | -81,279 | -20.02% | $7,054,014.00 |
| Divisadero Street Capital Management, LP | 30 Sep, 2025 | 298,000 | -199,716 | -40.13% | $6,475,540.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 286,421 | 71,869 | 33.50% | $6,223,928.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 245,051 | -17,160 | -6.54% | $5,324,958.00 |
| BNP PARIBAS FINANCIAL MARKETS | 30 Sep, 2025 | 229,790 | 142,094 | 162.03% | $4,993,337.00 |
| UBS Group AG | 30 Sep, 2025 | 220,361 | 7,877 | 3.71% | $4,788,445.00 |
| Soleus Capital Management, L.P. | 30 Sep, 2025 | 200,000 | -85,000 | -29.82% | $4,346,000.00 |